TECH
[CES 2021] LG Emphasized "Needs to Innovate Beyond..
[CES 2021] Sony Unveiled Its Latest Initiatives Sur..AUTO
Fourth Successive LE MANS WIN for TOYOTA GAZOO Rac..
Formula E Korea E-Prix 2020 Press ConferenceGAME
G-Star 2019 : Global Game Exhibition for the Whole..
2019 LoL Champions Korea Spring Media DayMedia
eCommerce leader Coupang Dives into Video Streamin..
EBS Well-Made Documentary ‘Singers – Laugh and C..
- Monday, September 20, 2021
-
AD Ports Group and Aqaba Development Corporation Sign Agreement for Tourism and Maritime Enhancement Projects in Aqaba - Jordan
New Cruise Terminal to be Developed by AD Ports Group as Part of Strategic Plan to Enhance Maritime and Tourism Sectors ABU DHABI, United Arab Emirates--(BUSINESS WIRE)--AD Ports Group, a leading facilitator of trade and logistics, has sig..
Sunday, September 19, 2021, 9:26 am
-
CStone presents preliminary results from a phase Ib study of the anti-CTLA-4 monoclonal antibody (mAb) CS1002 in combination with the anti-PD-1 mAb CS
SUZHOU, China, Sept. 19, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative cancer immunotherapies and precision ..
Sunday, September 19, 2021, 9:00 am
-
DeSHAZO Acquires Proto Machine Works
BIRMINGHAM, Ala.--(BUSINESS WIRE)--#elevatedservice--DeSHAZO (www.deshazo.com) announced today that it had acquired Proto Machine Works, LLC (www.protomachineworks.com) located in Huntsville, AL. Proto Machine Works designs and manufactures..
Sunday, September 19, 2021, 8:34 am
-
Datopotamab Deruxtecan Shows Encouraging Tumor Response in Patients with Advanced Non-Small Cell Lung Cancer with Actionable Genomic Alterations
Sub-analysis of TROPION-PanTumor01 phase 1 trial of datopotamab deruxtecan featured as late-breaking Mini Oral presentation at ESMO TROPION-Lung05 phase 2 trial currently enrolling patients to further evaluate the safety and efficacy of..
Sunday, September 19, 2021, 8:30 am
-
Seagen and Genmab Present Interim Results From the innovaTV 205 Study for Tisotumab Vedotin Combination Therapy Treatment of Recurrent or Metastatic C
- Tisotumab Vedotin in Combination with Carboplatin Showed Encouraging, Durable Anti-Tumor Activity as First-Line Treatment - - Tisotumab Vedotin in Combination with Pembrolizumab Showed Encouraging, Durable Anti-Tumor Activity in Previou..
Sunday, September 19, 2021, 8:30 am
- Barrett-Jackson Inaugural Houston Auction Hits $37.5 Million..2021-09-19 06:50
- Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Reduc..2021-09-19 04:30
- Personalis Receives New VA MVP Task Order and Record Quarter..2021-09-18 19:50
- “We’ve run out of staff. Kenney’s fourth wave is collapsi..2021-09-18 19:12
- Epsilyte Moving Expandable Polystyrene (EPS) Prices up to Ke..2021-09-18 18:13
- CStone presents preliminary results from a phase Ib study of..2021-09-19 09:00
- IMFINZI plus chemotherapy tripled patient survival at three ..2021-09-18 08:30
- IMFINZI Plus Chemotherapy Tripled Patient Survival at Three ..2021-09-18 08:30
- Celltrion’s monoclonal antibody treatment for COVID-19, ..2021-09-18 06:34
- Merck’s KEYTRUDA® (pembrolizumab) Demonstrated Superior R..2021-09-18 06:05
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) reduced the ris..2021-09-18 06:05
- Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy With ..2021-09-18 06:05
- ENHERTU® Reduced the Risk of Disease Progression or Death ..2021-09-18 06:05
- Spectrum Pharmaceuticals Presents Late Breaker Oral Presenta..2021-09-18 05:45
- 2021 CSCO | Henlius will Release Four Oral Presentations of ..2021-09-18 20:00
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated ro..2021-09-18 04:30
- ENHERTU® Demonstrated Robust and Durable Tumor Response of..2021-09-18 04:30
- Exelixis Announces Detailed Phase 1b Results from Cohort 6 o..2021-09-18 04:30
- Pipedrive Teams Up With World Cleanup Day as a Supporting Pa..2021-09-18 04:00
- XCMG Excavator Logs Cumulative Production and Sales of 200,0..2021-09-18 18:33
